Music L, Müller-Decker K, Amtmann E, Sauer G
Institute for Virus Research, German Cancer Research Center, Heidelberg.
Biochem Pharmacol. 1989 Jun 15;38(12):1941-5. doi: 10.1016/0006-2952(89)90492-9.
The xanthate tricyclodecan-9-yl-xanthogenate (D609) displays antiviral and antitumoral properties that are inversely proportional in vitro to the serum concentration. Accordingly, it has been found that D609 binds to serum albumin. Recently, we have reported that D609, in combination with undecanoic acid, has a synergistic antiviral effect, which appears, as shown here, to be due to competition for the same binding domain on serum albumin. Furthermore, undecanoic acid fosters the binding of D609 to the cell. Both the competition of D609 with monocarbonic acid for binding on serum albumin and the enhanced binding of xanthate to the cell are dependent, in accordance with previously reported results, on the chain length of the fatty acids. Eleven to 14 C-atoms (undecanoic, lauric and myristic acid) were found to be appropriate while shorter (C6) and larger (C18) monocarbonic acids were shown to lack synergistic properties.
黄原酸三环癸烷-9-基黄原酸酯(D609)具有抗病毒和抗肿瘤特性,在体外其活性与血清浓度呈反比。因此,已发现D609可与血清白蛋白结合。最近,我们报道D609与十一酸联合使用具有协同抗病毒作用,如此处所示,这似乎是由于二者竞争血清白蛋白上的同一结合域所致。此外,十一酸促进D609与细胞的结合。根据先前报道的结果,D609与一元羧酸竞争结合血清白蛋白以及黄原酸酯与细胞结合增强均取决于脂肪酸的链长。已发现含有11至14个碳原子的脂肪酸(十一酸、月桂酸和肉豆蔻酸)是合适的,而较短(C6)和较长(C18)的一元羧酸则缺乏协同特性。